{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T21:19:11Z","timestamp":1792876751033,"version":"4.5.0"},"reference-count":38,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T00:00:00Z","timestamp":1745107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Geriatr Psychiatry Neurol"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Recent research in Parkinson\u2019s disease (PD) has highlighted the potential therapies of continuous subcutaneous infusions (CSCI) of levodopa\/carbidopa (ND0612) and foslevodopa\/foscarbidopa (ABBV-951). This systematic review aims to explore their effectiveness and safety for PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Guided by the PRISMA statement, we systematically searched 3 electronic databases: MEDLINE, Embase, and Cochrane Central. We combined quantitative and qualitative data for synthesis and descriptive analysis. Quality assessment and risk of bias were evaluated by ROBINS-1 and Rob-2 criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 6 records with a total of 698 patients. CSCI therapies reduced motor symptoms in PD patients with levodopa-related motor fluctuations and clinical improvements. Infusions-site reactions were the main adverse event recorded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>ND0612 and ABBV-951 are promising options for enhancing motor control and quality of life in PD patients. However, further research is needed to assess long-term efficacy, safety, and comparisons with oral levodopa and device-aided treatments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/08919887251335011","type":"journal-article","created":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T09:03:16Z","timestamp":1745139796000},"page":"326-338","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy and Safety of Novel Continuous Subcutaneous Levodopa Infusion Therapies ND0612 and ABBV-951 for Parkinson\u2019s Disease: A Systematic Review"],"prefix":"10.1177","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6536-0862","authenticated-orcid":false,"given":"Matheus de Medeiros","family":"Fernandes","sequence":"first","affiliation":[{"name":"Medicine Department, State University of Rio Grande do Norte, Mossor\u00f3, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8809-8715","authenticated-orcid":false,"given":"Luis Ot\u00e1vio Souza","family":"Nogueira","sequence":"additional","affiliation":[{"name":"Medicine Department, State University of Amazonas, Manaus, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4836-5483","authenticated-orcid":false,"given":"Isabella Soares Marques","family":"Rabelo","sequence":"additional","affiliation":[{"name":"Medicine Department, State University of Cear\u00e1, Fortaleza, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8681-7464","authenticated-orcid":false,"given":"Louise Dalla Corte","family":"Dall\u00e9","sequence":"additional","affiliation":[{"name":"Medicine Department, Federal University of Rio Grande do Sul, Porto Alegre, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5048-9531","authenticated-orcid":false,"given":"Angela Maria Sandini","family":"Corso","sequence":"additional","affiliation":[{"name":"Medicine Department, Federal University of Paran\u00e1, Curitiba, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8973-0291","authenticated-orcid":false,"given":"Fernanda Medeiros","family":"Santos","sequence":"additional","affiliation":[{"name":"Medicine Department, State University of Rio Grande do Norte, Mossor\u00f3, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta Arb Saba Rodrigues","family":"Pinto","sequence":"additional","affiliation":[{"name":"Neurology Department, Federal University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8723-2757","authenticated-orcid":false,"given":"Vanderci","family":"Borges","sequence":"additional","affiliation":[{"name":"Neurology Department, Federal University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique Ballalai","family":"Ferraz","sequence":"additional","affiliation":[{"name":"Neurology Department, Federal University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9932-3528","authenticated-orcid":false,"given":"Dayany Leonel","family":"Boone","sequence":"additional","affiliation":[{"name":"Neurology Department, Federal University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,4,20]]},"reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.56.1.33"},{"key":"e_1_3_6_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.22360"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25364"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.1159\/000215875"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28215"},{"key":"e_1_3_6_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27338"},{"key":"e_1_3_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(15)00007-1"},{"key":"e_1_3_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(24)00052-8"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(22)00400-8"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.1036068"},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2021.09.024"},{"key":"e_1_3_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.prdoa.2024.100239"},{"key":"e_1_3_6_14_2","article-title":"Efficacy and safety of novel continuous subcutaneous infusion therapies ND0612 and ABBV-951 for patients with Parkinson's disease: a systematic review","author":"Fernandes M","year":"2024","unstructured":"Fernandes M, Nogueira L, Corso A, et al. Efficacy and safety of novel continuous subcutaneous infusion therapies ND0612 and ABBV-951 for patients with Parkinson's disease: a systematic review. PROSPERO. 2024. https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42024572821","journal-title":"PROSPERO"},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"e_1_3_6_16_2","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins JPT","year":"2024","unstructured":"Higgins JPT, Thomas J, Chandler J, et al., eds. Cochrane Handbook for Systematic Reviews of Interventions. London, UK: Cochrane; 2024. https:\/\/www.training.cochrane.org\/handbook"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22340"},{"key":"e_1_3_6_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/bf02260863"},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898"},{"key":"e_1_3_6_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919"},{"key":"e_1_3_6_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28758"},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-202285"},{"key":"e_1_3_6_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-023-00533-1"},{"key":"e_1_3_6_24_2","unstructured":"RevMan. Calculator [Internet]. [cited 2025 Mar 28]. https:\/\/training.cochrane.org\/resource\/revman-calculator"},{"key":"e_1_3_6_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/0962280216669183"},{"key":"e_1_3_6_26_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.1036068"},{"key":"e_1_3_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(06)70521-x"},{"key":"e_1_3_6_28_2","doi-asserted-by":"publisher","DOI":"10.3233\/jpd-212979"},{"key":"e_1_3_6_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/npjparkd.2015.11"},{"key":"e_1_3_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2014.09.013"},{"key":"e_1_3_6_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20279"},{"key":"e_1_3_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2016.11.017"},{"key":"e_1_3_6_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.4.733"},{"key":"e_1_3_6_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-018-0070-4"},{"key":"e_1_3_6_35_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000183146.78892.3f"},{"key":"e_1_3_6_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26564"},{"key":"e_1_3_6_37_2","doi-asserted-by":"crossref","unstructured":"Antonini A. New levodopa infusion systems for advanced Parkinson\u2019s disease. 2024. https:\/\/touchneurology.com\/parkinsons-disease\/journal-articles\/new-levodopa-infusion-systems-for-advanced-parkinsons-disease\/","DOI":"10.17925\/USN.2024.20.1.5"},{"key":"e_1_3_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105514"},{"key":"e_1_3_6_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15386"}],"container-title":["Journal of Geriatric Psychiatry and Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08919887251335011","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/08919887251335011","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08919887251335011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:17:03Z","timestamp":1777501023000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/08919887251335011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,20]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1177\/08919887251335011"],"URL":"https:\/\/doi.org\/10.1177\/08919887251335011","relation":{},"ISSN":["0891-9887","1552-5708"],"issn-type":[{"value":"0891-9887","type":"print"},{"value":"1552-5708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,20]]}}}